Pay in 4 interest-free payments of $5.70 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Schedule a consultation today to explore your options
Pros: Systemic peptide that does not need to be injected at the injury site to reach circulating therapeutic levels Widely available with third-party Certificates of Analysis from research chemical vendors Animal and cell-culture studies show consistent effects on wound closure speed and tissue remodeling across multiple tissue types (skin, cornea, cardiac) Cons: No completed human clinical trials specific to the TB-500 fragment
Research uses MT-1 to study whether the anti-inflammatory and melanogenic arms of MC1R biology can be pharmacologically dissected through downstream pathway selective interventions examining whether PKA inhibition differentially affects the two outputs and contributing to understanding of how MC1R-cAMP signalling branches to produce distinct cellular outcomes simultaneously
All protocols were approved by the Champalimaud Animal Ethical Committee and Portuguese institutional organizationsORBEA (rgo de Bem-Estar e tica Animal/Animal Welfare and Ethics Body) and DGAV (Direo Geral de Alimentao e Veterinria/Directorate General for Food and Veterinary)
US$ 24.56
US$ 22.94
US$ 24.83
US$ 26.25
US$ 20.46
US$ 25.28
US$ 23.37
US$ 25.55
US$ 28.80
US$ 25.35
US$ 22.02
